dr. holcombe on the progress of colorectal cancer and regorafenib
Published 11 years ago • 250 plays • Length 2:01Download video MP4
Download video MP3
Similar videos
-
1:04
dr. randall holcombe discusses regorafenib for metastatic colorectal cancer
-
1:04
dr. eckhardt on the role of regorafenib in colorectal cancer
-
0:58
managing colorectal cancer in patients who progress on regorafenib
-
9:34
regorafenib in colorectal cancer
-
1:11
dr. holcombe discusses stool dna test for colon cancer
-
1:08
dr. bendell on fda approval of regorafenib in liver cancer
-
1:04
exploring regorafenib and nivolumab as treatment for colorectal cancer
-
4:53
debate: salvage therapy for mcrc? - tas-102 followed by regorafenib
-
1:12
dr. lenz on choosing between regorafenib and tas-102 in crc
-
1:28
dr. overman on distinctions between regorafenib and tas-102 in crc
-
2:03
dr. axel grothey on the side effect profile of regorafenib in metastatic colorectal cancer
-
0:42
dr. bendell on the future of regorafenib for patients with crc
-
3:06
dr. finn on tivantinib and regorafenib for the treatment of liver cancer
-
8:47
colorectal cancer: dosing strategies with regorafenib
-
1:16
dr. eng on roles of regorafenib and tas-102 in crc treatment
-
5:25
second-line and salvage treatment of metastatic colorectal cancer
-
26:12
colon cancer: a medical oncologist’s perspective
-
1:05
dr. peeters on the utility of aflibercept in advanced colorectal cancer
-
5:31
practical advice for using regorafenib